CY1114025T1 - COMPOSITION FOR SUSPENSION - Google Patents
COMPOSITION FOR SUSPENSIONInfo
- Publication number
- CY1114025T1 CY1114025T1 CY20131100432T CY131100432T CY1114025T1 CY 1114025 T1 CY1114025 T1 CY 1114025T1 CY 20131100432 T CY20131100432 T CY 20131100432T CY 131100432 T CY131100432 T CY 131100432T CY 1114025 T1 CY1114025 T1 CY 1114025T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compositions
- suspension
- composition
- proteasome inhibitors
- cyclodextrin
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Οι συνθέσεις που περιλαμβάνουν έναν ή περισσότερους αδιάλυτους πρακτικά αναστολείς πρωτεασώματος και κυκλοδεξτρίνη, ιδιαίτερα μια υποκατεστημένη κυκλοδεξτρίνη, ουσιαστικά αυξάνουν τη διαλυτότητα αυτών των αναστολέων πρωτεασώματος και διευκολύνουν τη χορήγηση τους. Αυτές οι συνθέσεις περιλαμβάνουν προαιρετικά ένα ρυθμιστικό. Οι μέθοδοι θεραπευτικής αντιμετώπισης χρησιμοποιώντας αυτές τις συνθέσεις κοινοποιούνται επίσης.Compositions comprising one or more practically insoluble proteasome inhibitors and cyclodextrin, particularly a substituted cyclodextrin, substantially increase the solubility of these proteasome inhibitors and facilitate their administration. These compositions optionally include a buffer. Methods of treatment using these compositions are also disclosed.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63436604A | 2004-12-07 | 2004-12-07 | |
US65593005A | 2005-02-23 | 2005-02-23 | |
EP10178998A EP2260835B1 (en) | 2004-12-07 | 2005-12-07 | Composition for proteasome inhibition |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1114025T1 true CY1114025T1 (en) | 2016-07-27 |
Family
ID=58449087
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100432T CY1114025T1 (en) | 2004-12-07 | 2013-05-30 | COMPOSITION FOR SUSPENSION |
CY20151100923T CY1117507T1 (en) | 2004-12-07 | 2015-10-15 | COMPOSITION FOR SUSPENSION |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100923T CY1117507T1 (en) | 2004-12-07 | 2015-10-15 | COMPOSITION FOR SUSPENSION |
Country Status (1)
Country | Link |
---|---|
CY (2) | CY1114025T1 (en) |
-
2013
- 2013-05-30 CY CY20131100432T patent/CY1114025T1/en unknown
-
2015
- 2015-10-15 CY CY20151100923T patent/CY1117507T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CY1117507T1 (en) | 2017-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111489T1 (en) | COMPOUNDS FOR SUSPENSION | |
CY1116693T1 (en) | A combination of azelastin and cycloneside | |
NO2023022I1 (en) | cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate | |
CY1113192T1 (en) | UNIONS AND METHODS FOR THE SUSPENSION OF SUSPENSION PROGRESS THROUGH AURORA SUSPENSION | |
CY1113386T1 (en) | PROJECTOR SUSPENSIONS | |
EA200701065A1 (en) | INJECTABLE COMPOSITIONS CONTAINING NANODISPERS Olanzapine | |
CY1116373T1 (en) | PHARMACEUTICAL PARTICLES CONTAINING METHYLNALTREXON | |
CY1113963T1 (en) | PHARMACEUTICAL COMPOSITIONS WHICH INCLUDE ACTIVIA-COMPETITORS AND USE THESE IN PREVENTION OR MULTIPLE | |
CY1107294T1 (en) | LOCAL COMPOSITION CONTAINING A VITAMIN D OR A VERSION OF VITAMIN D AND A VULNERABLE CYTICOSTEROID | |
NO20081554L (en) | Isoindollide compounds and compositions comprising the same, and their use | |
CY1106679T1 (en) | AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS | |
EA200802390A1 (en) | CONSENTS OF ANALOGUES OF AZIRIDELEPOTILON AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
MXPA05013977A (en) | Methods and compositions for treating amyloid-related diseases. | |
EA200501928A1 (en) | Pyrrolodihydroisoquinols as inhibitors of PDE10 | |
CY1109916T1 (en) | Benzimidazolo-thiophene compounds as PLK inhibitors | |
CY1111983T1 (en) | PHARMACEUTICAL COMPOSITION AND METHOD OF USE OF ANTIFICIAL AGENT IN COMBINATION | |
CY1109465T1 (en) | NEW PHARMACEUTICAL MEDICINES FORMONTAFINILIS | |
NO20063293L (en) | Pharmaceutical compounds | |
CY1117507T1 (en) | COMPOSITION FOR SUSPENSION | |
CY1114113T1 (en) | COMBINATION OF A VASCULAR IF VASCULAR INHIBITOR AND A BETA-INHIBITOR | |
CY1114373T1 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING DROCHIDORA | |
CY1114328T1 (en) | AMINOCINOLONES AS GSK-3 INHIBITORS | |
CY1114511T1 (en) | CARBONYLAMINE PYRROLOPYRAZOLES, POSSIBLE CHINASE INHIBITORS |